Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism PTEN inhibitors(Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors), RNAi(RNA interference) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Spinal Cord Injuries | Preclinical | United States | 23 Nov 2016 |





